The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study - Articles - Gynecology · Urology

Uro-Oncology

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000-2016. Nationwide, population-based study in Sweden

BJU Int.

Orrason AW, Westerberg M, Garmo H, Franck Lissbrant I, Robinson D, Stattin P

doi: 10.1111/bju.15077.

Uro-Oncology

Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study

Prostate.

Lundgren PO, Kjellman A, Norming U, Gustafsson O

doi: 10.1002/pros.23991.

Uro-Oncology

Red and processed meat, poultry, fish and egg intakes and cause-specific and all-cause mortality among men with non-metastatic prostate cancer in a US Cohort

Cancer Epidemiol Biomarkers Prev.

Wang Y, Jacobs EJ, Shah RA, Stevens VL, Gansler T, McCullough ML

doi: 10.1158/1055-9965.EPI-19-1426.

Uro-Oncology

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Prostate Cancer Prostatic Dis.

Beckmann K, Garmo H, Lindahl B, Holmberg L, Stattin P, Adolfsson J, Cruickshank JK, Van Hemelrijck M

doi: 10.1038/s41391-020-0220-8.

Uro-Oncology

Associations among statins, preventive care, and prostate cancer mortality

Prostate Cancer Prostatic Dis.

Kumar A, Riviere P, Luterstein E, Nalawade V, Vitzthum L, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS

doi: 10.1038/s41391-020-0207-5.

Uro-OncologyReproductive Health

Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies

Fertil Steril.

Del Giudice F, Kasman AM, De Berardinis E, Busetto GM, Belladelli F, Eisenberg ML

doi: 10.1016/j.fertnstert.

Benign Prostatic Hyperplasia (BPH)

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

Prostate Cancer Prostatic Dis

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ

doi: 10.1038/s41391-017-0031-8.

Uro-Oncology

Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study

Eur Urol.

Stavrinides V, Giganti F, Trock B, Punwani S, Allen C, Kirkham A, Freeman A, Haider A, Ball R, McCartan N, Whitaker H, Orczyk C, Emberton M, Moore CM

doi: 10.1016/j.eururo.2020.03.035.

Uro-Oncology

Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS)

J Urol.

Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW

doi: 10.1016/j.juro.2018.07.065.

Related content

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000-2016. Nationwide, population-based study in Sweden

Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study

Red and processed meat, poultry, fish and egg intakes and cause-specific and all-cause mortality among men with non-metastatic prostate cancer in a US Cohort

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Associations among statins, preventive care, and prostate cancer mortality

Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study

Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS)